Sabri KÖSEOĞLU, Kürşat Murat ÖZCAN, Aykut İKİNCİOĞULLARI, Mehmet Ali ÇETİN, Talih ÖZDAŞ, Sibel ÖZDAŞ, Serdar ENSARİ, Hacı Hüseyin DERE

Evaluation of autoinflammatory disease genes in nasal polyposis

To investigate cold-induced autoinflammatory syndrome 1 (CIAS1) gene polymorphisms that cause autoinflammatory diseases in patients with nasal polyposis (NP). Materials and methods: The study included 30 patients diagnosed with NP and 30 healthy age-matched individuals as a control group. CIAS1 polymorphisms were assessed by DNA sequence analysis. Patients with nasal polyps and the control group were compared in terms of gene polymorphisms. Each of the 8 polymorphisms of the CIAS1 gene was analyzed separately in the patient group. Results: The most frequently observed polymorphisms in the patient group were c.732G > A in 83%, c.663C > T in 23%, and c.1308C > A in 23% of the patients. c.732G > A polymorphism was evaluated separately. Guanine was transformed to adenine at the 732nd nucleotide position of the CIAS1 gene in the cDNA of chromosome 1. Conclusion: The CIAS1 gene c.732G > A polymorphism was thought to be responsible for an increase in disease susceptibility. The frequency of the \"A\" allele is higher in the patient group compared to the control group. Autoinflammatory diseases seem like a candidate to be one of these factors. This is the first report to define the role of autoinflammatory diseases among these factors.

Anahtar Kelimeler:

Nasal polyps, hereditary autoinflammatory disease, polymorphism, inflammation, CIAS1

Evaluation of autoinflammatory disease genes in nasal polyposis

Keywords:

Nasal polyps, hereditary autoinflammatory disease, polymorphism, inflammation, CIAS1,

PDF

___

Tewfik MA, Bosse Y, Al-Shemari H, Desrosiers M. Genetics of chronic rhinosinusitis: a primer. J Otolaryngol Head Neck Surg 2010; 39: 62–68.
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319–325.
de Castro MC, Assunção E, de Castro MM, Araşjo RN, Guimarães RE, Nunes FB. Effect of mitomycin C in eosinophilic nasal polyposis, in vivo: concentration of IL5 and GM-CSF, RT-PCR. Braz J Otorhinolaryngol 2006; 72: 38–42.
Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology 2011; 49: 525–532. 8. Fritz SB, Terrell JE, Conner ER, Kukowska-Latallo JF, Baker JR. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003; 112: 1057–1063.
Zielinska-Blizniewska H, Sitarek P, Milonski J, Dziki L, Przybylowska K, Olszewski J, Majsterek I. Association of the -33C/G OSF-2 and the 140A/G LF gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population. Mol Biol Rep 2012; 39: 5449–5457.
Batikhan H, Gokcan MK, Beder E, Akar N, Ozturk A, Gerceker M. Association of the tumor necrosis factor-alpha 2308 G/A polymorphism with nasal polyposis. Eur Arch Otorhinolaryngol 2010; 267: 903–908.
Kosugi EM, de Camargo-Kosugi CM, Hirai ER, Mendes- Neto JA, Gregorio LC, Guerreiro-da-Silva ID, Weckx LL. Interleukin-6 -174 G/C promoter gene polymorphism in nasal polyposis and asthma. Rhinology 2013; 51: 70–76.
Sitarek P, Zielinska-Blizniewska H, Dziki L, Milonski J, Przybylowska K, Mucha B, Olszewski J, Majsterek I. Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population. DNA Cell Biol 2012; 31: 1258–1266.
Bae JS, Pasaje CF, Park BL, Cheong HS, Kim JH, Uh ST, Park CS, Shin HD. Genetic association analysis of CIITA variations with nasal polyp pathogenesis in asthmatic patients. Mol Med Rep 2013; 7: 927–934.
Yazdani N, Amoli MM, Naraghi M, Mersaghian A, Firouzi F, Sayyahpour F, Mokhtari Z. Association between the functional polymorphism C-159T in the CD14 promoter gene and nasal polyposis: potential role in asthma. J Investig Allergol Clin Immunol 2012; 22: 406–411.
Apuhan T, Gepdiremen S, Arslan AO, Aktas G. Evaluation of patients with nasal polyps about the possible association of desmosomal junctions, RORA and PDE4D gene. Eur Rev Med Pharmacol Sci 2013; 17: 2680–2683.
Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008; 4: 481–489.
Jesus AA, Silva CA, Segundo GR, Aksentijevich I, Fujihira E, Watanabe M, Carneiro-Sampaio M, Duarte AJ, Oliveira JB. Phenotype-genotype analysis of cryopyrin-associated periodic syndromes (CAPS): description of a rare non-exon 3 and a novel CIAS1 missense mutation. J Clin Immunol 2008; 28: 134–138.
Frenkel J, van Kempen MJ, Kuis W, van Amstel HK. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1. Arthritis Rheum 2004; 50: 2719–2720.
Matsubayashi T, Sugiura H, Arai T, Oh-Ishi T, Inamo Y. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Acta Paediatr 2006; 95: 246–249.
Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004; 103: 2809–2815.
Verma D, Särndahl E, Andersson H, Eriksson P, Fredrikson M, Jönsson JI, Lerm M, Söderkvist P. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production. PLoS One 2012; 7:e34977.